Abstract
This review summarizes the latest advances in treating and preventing Clostridium difficile infection (CDI), the most common infectious disease cause of nosocomial diarrhea in adults in developed countries. As customary antibiotic therapies against C. difficile, metronidazole and vancomycin, are broad spectrum, they affect greatly the gut microbiota, which result in very high recurrence rates. Therefore, new strategies are researched intensively. New therapies focus on limiting further destruction of the gut microbiota or restoring the microbiota to its pre-destructed state. These include new antibiotics, such as fidaxomicin, which demonstrates reduced CDI recurrences, among other new drugs, biotherapeutic strategies, mainly fecal microbiota transplantation but also competitive inhibition with non-toxigenic strains of C. difficile, and finally, monoclonal antibodies against C. difficile toxins which offer protection against recurrences.
References
Mar 8, 2002·Annals of Surgery·Ramsey M DallalRichard L Simmons
Jun 30, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Fred A ZarMelinda B Davis
Jan 18, 2008·The Journal of Infectious Diseases·Ju Young ChangVincent B Young
Oct 29, 2008·Antimicrobial Agents and Chemotherapy·Thomas J LouieManuel Mah
Feb 4, 2011·The New England Journal of Medicine·Thomas J LouieUNKNOWN OPT-80-003 Clinical Study Group
Mar 19, 2011·Journal of Medical Microbiology·Ciarán P Kelly, Lorraine Kyne
Aug 17, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kathleen M MullaneSherwood L Gorbach
Feb 1, 2012·The American Journal of Gastroenterology·Matthew J HamiltonAlexander Khoruts
Feb 11, 2012·The Lancet Infectious Diseases·Oliver A CornelyUNKNOWN OPT-80-004 Clinical Study Group
Apr 28, 2012·Vaccine·Jing-Hui TianDavid C Flyer
Jun 12, 2012·Vaccine·Ginamarie FogliaPatricia J Freda Pietrobon
Jan 18, 2013·The New England Journal of Medicine·Els van NoodJosbert J Keller
Jan 22, 2013·Gut Microbes·Matthew J HamiltonMichael J Sadowsky
May 1, 2013·Microbiology·Robert G K DonaldAnnaliesa S Anderson
Oct 17, 2013·The Journal of Antimicrobial Chemotherapy·C H ChiltonM H Wilcox
Oct 23, 2014·Nature·Charlie G BuffieEric G Pamer
Feb 14, 2015·Infectious Disease Clinics of North America·Chandrabali Ghose, Ciarán P Kelly
Feb 26, 2015·The New England Journal of Medicine·Fernanda C LessaL Clifford McDonald
May 6, 2015·JAMA : the Journal of the American Medical Association·Dale N GerdingStephen Villano
Aug 8, 2015·Antimicrobial Agents and Chemotherapy·Thomas LouieOliver A Cornely
Jan 13, 2016·JAMA : the Journal of the American Medical Association·Christine H LeePeter T Kim
Dec 25, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Susy S HotaSusan M Poutanen
Jan 26, 2017·The New England Journal of Medicine·Mark H WilcoxUNKNOWN MODIFY I and MODIFY II Investigators
May 4, 2017·The Lancet Infectious Diseases·Richard J VickersUNKNOWN CoDIFy study group
Sep 30, 2017·The Journal of Antimicrobial Chemotherapy·P DaleyY Murata
Dec 23, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Yafet MamoColleen S Kraft
Dec 24, 2017·The Lancet Infectious Diseases·Benoit GueryUNKNOWN EXTEND Clinical Study Group